首页|The latest research progress of novel coronavirus "Omicron sub‑variant BA.5"
The latest research progress of novel coronavirus "Omicron sub‑variant BA.5"
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
万方数据
Since the outbreak of COVID‑19, severe acute respiratory syndrome coronavirus 2 genome is still mutating, forming a variety of variants with strong transmission capacity, causing the spread of the epidemic worldwide, posing a serious threat to people's physical and mental health, and posing a major challenge to global public health. Omicron remains the main variant in several outbreaks worldwide, accounting for about 99％ of the global genetic sequence. Recently, the World Health Organization announced that the subvariant of Omicron BA.5 has been found in more than 100 countries and regions around the world, causing the global epidemic rebound. However, there are few studies on the subvariant BA.5. This article reviews the latest research progress in epidemiology, infectivity, pathogenicity, vaccine and monoclonal antibody protection against Omicron subvariant BA.5, in order to provide reference for scientific prevention and control of Omicron subvariant BA.5.
SARS‑CoV‑2Omicron variantsBA.5 sub‑variantProgess
WANG Cai?hong、YAO Xiao?wen、WANG Rong、ZHOU Yu?xia、Li Bin、YU Xiao?hui、ZHANG Jiu?cong
展开 >
The First Clinical Medical College of Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China
Department of Gastroenterology,the 940 Hospital of Joint Logistic Support Force of PLA,Lanzhou 730050,China
COVID?19 Emergency Medical Research Project of 940 HospitalGeneral Project of Huoshenshan Hospital Scientific Research Fund
万方数据
